Arax Advisory Partners’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-139	Closed	-$4.73K	–	2490
2024 Q3	$4.73K	Hold	139	–	–	﹤0.01%	1737
2024 Q2	$5.15K	Buy	+139	New	+$5.15K	﹤0.01%	1581